400 related articles for article (PubMed ID: 14551885)
21. Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production.
de Noronha AL; Báfica A; Nogueira L; Barral A; Barral-Netto M
Pathol Res Pract; 2008; 204(3):155-61. PubMed ID: 18096327
[TBL] [Abstract][Full Text] [Related]
22. [A serum immunoglobulin study in patients with tuberculosis and human immunodeficiency virus infection].
Navarro V; Tuset C; Guix J; Nieto A; Bernacer B; Roig P
Rev Clin Esp; 1992 Apr; 190(6):291-4. PubMed ID: 1598426
[TBL] [Abstract][Full Text] [Related]
23. Influence of microbial infections on the progression of HIV disease.
Blanchard A; Montagnier L; Gougeon ML
Trends Microbiol; 1997 Aug; 5(8):326-31. PubMed ID: 9263412
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.
Canueto-Quintero J; Caballero-Granado FJ; Herrero-Romero M; Domínguez-Castellano A; Martín-Rico P; Verdú EV; Santamaría DS; Cerquera RC; Torres-Tortosa M;
Clin Infect Dis; 2003 Aug; 37(4):584-90. PubMed ID: 12905144
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of HIV-infected tuberculosis patients in Thailand.
Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
[TBL] [Abstract][Full Text] [Related]
26. Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.
Kizza HM; Rodriguez B; Quinones-Mateu M; Mirza M; Aung H; Yen-Lieberman B; Starkey C; Horter L; Peters P; Baseke J; Johnson JL; Toossi Z
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1298-304. PubMed ID: 16275944
[TBL] [Abstract][Full Text] [Related]
27. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
Fantuzzi L; Belardelli F; Gessani S
J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
[TBL] [Abstract][Full Text] [Related]
28. Correlates for disease progression and prognosis during concurrent HIV/TB infection.
Djoba Siawaya JF; Ruhwald M; Eugen-Olsen J; Walzl G
Int J Infect Dis; 2007 Jul; 11(4):289-99. PubMed ID: 17446108
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.
Toossi Z; Mayanja-Kizza H; Baseke J; Peters P; Wu M; Abraha A; Aung H; Okwera A; Hirsch C; Arts E
Clin Exp Immunol; 2005 Nov; 142(2):327-32. PubMed ID: 16232220
[TBL] [Abstract][Full Text] [Related]
30. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.
Kibiki GS; Mulder B; van der Ven AJ; Sam N; Boeree MJ; van der Zanden A; Dolmans WM
Trop Med Int Health; 2007 Oct; 12(10):1210-7. PubMed ID: 17956503
[TBL] [Abstract][Full Text] [Related]
31. The immunological status of newly diagnosed tuberculosis patients co-infected with human immunodeficiency virus-1 in Adama Hospital, Ethiopia.
Ligidi T; Gebre-Selassie S; Tsegaye A
Ethiop Med J; 2011 Apr; 49(2):75-83. PubMed ID: 21796907
[TBL] [Abstract][Full Text] [Related]
32. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
33. TB spikes viral load in HIV patients.
AIDS Alert; 1996 Jul; 11(7):81-2. PubMed ID: 11363552
[TBL] [Abstract][Full Text] [Related]
34. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
35. Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study.
Gennaro ML; Affouf M; Kanaujia GV; Brusasca PN; Mangura B; Reichman L
Int J Tuberc Lung Dis; 2007 Jun; 11(6):624-31. PubMed ID: 17519093
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
Colebunders R; John L; Huyst V; Kambugu A; Scano F; Lynen L
Int J Tuberc Lung Dis; 2006 Sep; 10(9):946-53. PubMed ID: 16964782
[TBL] [Abstract][Full Text] [Related]
37. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.
Toossi Z; Mayanja-Kizza H; Hirsch CS; Edmonds KL; Spahlinger T; Hom DL; Aung H; Mugyenyi P; Ellner JJ; Whalen CW
Clin Exp Immunol; 2001 Feb; 123(2):233-8. PubMed ID: 11207653
[TBL] [Abstract][Full Text] [Related]
38. Mycobacterium tuberculosis and HIV co-infection in the lung: synergic immune dysregulation leading to disease progression.
Bocchino M; Sanduzzi A; Bariffi F
Monaldi Arch Chest Dis; 2000 Oct; 55(5):381-8. PubMed ID: 11213375
[TBL] [Abstract][Full Text] [Related]
39. Determinants of the natural history of human immunodeficiency virus type 1 infection.
Phair JP
J Infect Dis; 1999 Mar; 179 Suppl 2():S384-6. PubMed ID: 10081512
[TBL] [Abstract][Full Text] [Related]
40. Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.
Talbot EA; Hay Burgess DC; Hone NM; Iademarco MF; Mwasekaga MJ; Moffat HJ; Moeti TL; Mwansa RA; Letsatsi P; Gokhale NT; Kenyon TA; Wells CD
Clin Infect Dis; 2004 Jul; 39(1):e1-7. PubMed ID: 15206074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
